Steven Cohen’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.9M Sell
1,604,466
-1,471,658
-48% -$31.4M 0.04% 657
2026
Q2
$88.8M Sell
3,076,124
-809,893
-21% -$21.8M 0.1% 237
2026
Q1
$70.3M Buy
3,886,017
+1,101,211
+40% +$21M 0.09% 257
2025
Q4
$60.5M Buy
+2,784,806
New +$79.8M 0.07% 332
2025
Q3
– Sell
-227,906
Closed -$8.09M – 2517
2025
Q2
$8.09M Buy
+227,906
New +$7.39M 0.02% 817
2024
Q4
– Sell
-195,371
Closed -$9.5M – 2273
2024
Q3
$9.5M Sell
195,371
-109,149
-36% -$5.81M 0.02% 662
2024
Q2
$13.5M Buy
+304,520
New +$14M 0.04% 512
2022
Q4
– Sell
-107,000
Closed -$4.37M – 1671
2022
Q3
$4.37M Sell
107,000
-105,900
-50% -$4.97M 0.02% 760
2022
Q2
$11.7M Buy
+212,900
New +$8.99M 0.05% 473
2021
Q2
– Sell
-1,639,200
Closed -$47.6M – 1078
2021
Q1
$47.6M Buy
+1,639,200
New +$44.7M 0.22% 116

Other funds holding LEGN

Steven Cohen's LEGN Position: Q3 2026 in Review

Steven Cohen reduced its Legend Biotech (LEGN) stake by 48% in Q3 2026, selling an estimated $31.4M and leaving 1,604,466 shares worth $31.9M. The position accounts for 0.04% of the portfolio, ranked #657.

Steven Cohen first reported a position in LEGN in Q1 2021 and has held it in 10 quarters since. The position peaked at $88.8M in Q2 2026. 197 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Steven Cohen held 1,604,466 shares of Legend Biotech worth $31.9M as of Q3 2026.
  • Steven Cohen sold 1,471,658 Legend Biotech shares in Q3 2026, an estimated $31.4M.
  • Legend Biotech made up 0.04% of Steven Cohen's portfolio in Q3 2026, its #657 holding.
  • Steven Cohen first reported a position in Legend Biotech in Q1 2021 and has held it in 10 quarters since.
  • Steven Cohen's Legend Biotech position peaked at $88.8M in Q2 2026.
  • 197 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.